Design of new secreted phospholipase A2 inhibitors based on docking calculations by modifying the pharmacophore segments of the FPL67047XX inhibitor.

Journal of Computer-aided Molecular Design
Varnavas D MouchlisGeorge Kokotos

Abstract

Docking calculations that allow the estimation of the binding energy of small ligands in the GIIA sPLA(2) active site were used in a structure-based design protocol. Four GIIA sPLA(2) inhibitors co-crystallised with the enzyme, were used for examining the enzyme active site and for testing the FlexX in SYBYL 6.8 molecular docking program to reproduce the crystallographic experimental data. The FPL67047XX inhibitor was chosen as a prototype structure for applying free energy perturbation (FEP) studies. Structural modifications of the initial structure of the FPL67047XX inhibitor (IC(50) 0.013 microM) were performed in an effort to optimise the interactions in the GIIA sPLA(2) active site. The structural modifications were based on: (1) the exploration of absolute configuration (i.e. comparison of the binding score of (R)- and (S)-enantiomers); (2) bioisosterism (i.e. replacement of the carboxylate group with the bioisosteric sulphonate and phosphonate groups); (3) insertion of substituents that fit better in the active site. The generated new structures exhibited higher binding energy. Such structures may spark off the interest of medicinal chemists for synthesizing potentially more active GIIA sPLA(2) inhibitors.

References

Dec 14, 1990·Science·D L ScottP B Sigler
Feb 29, 1988·Biochemical and Biophysical Research Communications·F A LaiG Meissner
May 1, 1983·Prostaglandins, Leukotrienes, and Medicine·W C ReevesJ R Luderer
Jul 7, 1995·Journal of Medicinal Chemistry·A R OrtizR C Wade
Mar 4, 1994·Journal of Medicinal Chemistry·H G BeatonD H Robinson
Dec 1, 1995·Current Opinion in Biotechnology·R C Jackson
Dec 20, 1996·Journal of Medicinal Chemistry·S E DraheimJ P Wery
Dec 20, 1996·Journal of Medicinal Chemistry·I TeshirogiM Ohtani
Nov 18, 2000·Biochimica Et Biophysica Acta·T J NevalainenJ M Grönroos
Nov 18, 2000·Biochimica Et Biophysica Acta·L W Tjoelker, D M Stafforini
Dec 19, 1996·Chemical Reviews·George A. Patani, Edmond J. LaVoie
Sep 5, 2002·Journal of the American Chemical Society·Mutasem Omar SinnokrotC David Sherrill
Oct 5, 2002·Journal of Computer-aided Molecular Design·R D TaylorJ W Essex
Mar 5, 2003·Chembiochem : a European Journal of Chemical Biology·Karl A HansfordDavid P Fairlie
Aug 5, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Bruno L Diaz, Jonathan P Arm
Jan 11, 2005·Current Medicinal Chemistry·Lídia Moreira Lima, Eliezer J Barreiro
Apr 28, 2005·Current Pharmaceutical Design·M C MeyerJ McHowat
Dec 28, 2005·Current Medicinal Chemistry·Robert C Reid
Sep 16, 2006·Biochimica Et Biophysica Acta·Ralph H Schaloske, Edward A Dennis
Apr 4, 2007·The Journal of Experimental Medicine·William R HendersonMichael H Gelb
Apr 15, 2008·Annual Review of Biochemistry·Gérard Lambeau, Michael H Gelb
Jul 9, 2008·Journal of Medicinal Chemistry·Rob C OslundMichael H Gelb
Oct 15, 2008·Cardiovascular Drugs and Therapy·Boris B Boyanovsky, Nancy R Webb
Oct 22, 2008·Cardiovascular Drugs and Therapy·John E Burke, Edward A Dennis
Mar 12, 2009·Combinatorial Chemistry & High Throughput Screening·Tiziano Tuccinardi

❮ Previous
Next ❯

Citations

Jan 18, 2016·Advances in Biological Regulation·Varnavas D Mouchlis, Edward A Dennis
May 11, 2011·Bioorganic & Medicinal Chemistry·Yiran WuLuhua Lai
Dec 26, 2018·Chemical Biology & Drug Design·Shengde ZhangAixia Yan
Aug 28, 2010·Journal of Chemical Information and Modeling·Varnavas D MouchlisGeorge Kokotos
Feb 12, 2013·Journal of Chemical Theory and Computation·Alexey A ZeifmanGhermes G Chilov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.